Skip to main content

Research

We are continually working to progress next generation gene therapy treatments for life-threatening diseases. We are developing programs for rare genetic diseases with both systemic and local delivery.

We’re determined to provide life-changing DNA-based therapies. 

Tyris’ pipeline currently focuses on several high unmet need genetic diseases and can be applied on any therapeutic area where current gene therapy platforms have shown strong limitations.

Liver

Kidney

Skin

Brain

Lungs

Eyes

Promising further applications of our technology platform to fuel innovation in more prevalent therapeutic approaches.

Car-T’s

Vaccines

Antibodies

Gene editing

Partnership

At Tyris we are committed to develop our own pipeline of transformative non-viral gene therapies. With that purpose in mind, we are also open to combine our expertise, collaborating with external partners to progress jointly our science and deliver transformative medicines to patients.

Almirall & Tyris Therapeutics

We are combining our expertise in novel non-viral gene therapy technology with Almirall’s leading expertise in medical dermatology and are committed together to deliver breakthrough medicines to patients in that field.